375 related articles for article (PubMed ID: 24253140)
1. A randomized, controlled, double-blind crossover study on the effects of 1-L infusions of 6% hydroxyethyl starch suspended in 0.9% saline (voluven) and a balanced solution (Plasma Volume Redibag) on blood volume, renal blood flow velocity, and renal cortical tissue perfusion in healthy volunteers.
Chowdhury AH; Cox EF; Francis ST; Lobo DN
Ann Surg; 2014 May; 259(5):881-7. PubMed ID: 24253140
[TBL] [Abstract][Full Text] [Related]
2. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers.
Lobo DN; Stanga Z; Aloysius MM; Wicks C; Nunes QM; Ingram KL; Risch L; Allison SP
Crit Care Med; 2010 Feb; 38(2):464-70. PubMed ID: 19789444
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.
Chowdhury AH; Cox EF; Francis ST; Lobo DN
Ann Surg; 2012 Jul; 256(1):18-24. PubMed ID: 22580944
[TBL] [Abstract][Full Text] [Related]
4. Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine(R)) and 6% hydroxyethyl starch (Voluven(R)) on blood volume.
Awad S; Dharmavaram S; Wearn CS; Dube MG; Lobo DN
Br J Anaesth; 2012 Aug; 109(2):168-76. PubMed ID: 22508964
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, double-blind crossover study on the effects of isoeffective and isovolumetric intravenous crystalloid and gelatin on blood volume, and renal and cardiac hemodynamics.
Bradley CR; Bragg DD; Cox EF; El-Sharkawy AM; Buchanan CE; Chowdhury AH; Macdonald IA; Francis ST; Lobo DN
Clin Nutr; 2020 Jul; 39(7):2070-2079. PubMed ID: 31668721
[TBL] [Abstract][Full Text] [Related]
6. Infusion of 7.2% NaCl/6% hydroxyethyl starch 200/0.5 in on-pump coronary artery bypass surgery patients: a randomized, single-blind pilot study.
Lomivorotov VV; Fominskiy EV; Efremov SM; Nepomniashchikh VA; Lomivorotov VN; Chernyavskiy AM; Shilova AN; Karaskov AM
Shock; 2014 Mar; 41(3):193-9. PubMed ID: 24549094
[TBL] [Abstract][Full Text] [Related]
7. [Efficiency of hydroxyethyl starch use for arterial hypotension and shock in early postoperative period].
Kriuchko DS; Ionov OV; Balashova EN; Kirtbaia AR; Nikitina IV; Krasnova LA; Sharipova LV; Terliakova OIu; Milaia OV
Anesteziol Reanimatol; 2013; (5):58-62. PubMed ID: 24624861
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
[TBL] [Abstract][Full Text] [Related]
9. [Small volume resuscitation for acute intraoperative haemorrhage: comparison of 7.5% saline and 6% hydroxyethyl starch].
Ratajczak J; Szczepanik AB; Meissner AJ; Ostas A; Wiszniewski A; Bilski R
Anestezjol Intens Ter; 2009; 41(1):6-10. PubMed ID: 19517670
[TBL] [Abstract][Full Text] [Related]
10. Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study.
Lobo DN; Stanga Z; Simpson JA; Anderson JA; Rowlands BJ; Allison SP
Clin Sci (Lond); 2001 Aug; 101(2):173-9. PubMed ID: 11473492
[TBL] [Abstract][Full Text] [Related]
11. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients.
Van der Linden P; De Villé A; Hofer A; Heschl M; Gombotz H
Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of hydroxyethyl starch 6% 130/0.4 in a balanced electrolyte solution (Volulyte) during cardiac surgery.
Base EM; Standl T; Lassnigg A; Skhirtladze K; Jungheinrich C; Gayko D; Hiesmayr M
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):407-14. PubMed ID: 21345699
[TBL] [Abstract][Full Text] [Related]
13. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
14. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5.
Langeron O; Doelberg M; Ang ET; Bonnet F; Capdevila X; Coriat P
Anesth Analg; 2001 Apr; 92(4):855-62. PubMed ID: 11273914
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
[TBL] [Abstract][Full Text] [Related]
16. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
[TBL] [Abstract][Full Text] [Related]
17. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery.
Boldt J; Schöllhorn T; Münchbach J; Pabsdorf M
Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812
[TBL] [Abstract][Full Text] [Related]
18. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution.
Standl T; Burmeister MA; Schroeder F; Currlin E; Schulte Esch J; Freitag M; Schulte Esch J
Anesth Analg; 2003 Apr; 96(4):936-943. PubMed ID: 12651637
[TBL] [Abstract][Full Text] [Related]
20. The intraoperative therapeutic equivalence of balanced vs saline-based 6% hydroxyethyl starch 130/0.4 and their influence on perioperative acid-base status and renal functions.
Helmy A; Mukhtar A; Ahmed A; Sief NE; Hussein A
J Clin Anesth; 2016 Aug; 32():267-73. PubMed ID: 27290988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
